Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&

Updated on: October 17,2023

Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&

Updated on:October 17,2023

Dietary selenium may help fight acute myeloid leukemia, researchers report

by Chuck Gill,Pennsylvania State UniversityGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112794Selenium-enriched diets may help ward off myeloid leukemia,

Updated on: October 30,2023

Dietary selenium may help fight acute myeloid leukemia, researchers report

by Chuck Gill,Pennsylvania State UniversityGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112794Selenium-enriched diets may help ward off myeloid leukemia,

Updated on:October 30,2023

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on: December 19,2023

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on:December 19,2023

Pembrolizumab Active in Advanced Nasopharyngeal Carcinoma

August 29, 2017Jason HarrisPembrolizumab (Keytruda) induced an overall response rate of 25.9% and was well tolerated in patients with PD-L1–positive recurrent or metastatic nasopharyngeal carcinoma.Na

Updated on: October 24,2023

Pembrolizumab Active in Advanced Nasopharyngeal Carcinoma

August 29, 2017Jason HarrisPembrolizumab (Keytruda) induced an overall response rate of 25.9% and was well tolerated in patients with PD-L1–positive recurrent or metastatic nasopharyngeal carcinoma.Na

Updated on:October 24,2023

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on: December 18,2023

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on:December 18,2023

Fox Chase Physician Wins Best Poster Award at Breast Cancer Meeting for Research on Surgery to

May 26, 2023Fox Chase Cancer CenterAustin D. Williams, MD, MSEd, of Fox Chase Cancer Center, received the Best Poster Award at the recent 24th Annual Meeting of the American Society of Breast Surgeons

Updated on: October 15,2023

Fox Chase Physician Wins Best Poster Award at Breast Cancer Meeting for Research on Surgery to

May 26, 2023Fox Chase Cancer CenterAustin D. Williams, MD, MSEd, of Fox Chase Cancer Center, received the Best Poster Award at the recent 24th Annual Meeting of the American Society of Breast Surgeons

Updated on:October 15,2023

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci

Updated on: October 15,2023

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci

Updated on:October 15,2023

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on: October 27,2023

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on:October 27,2023

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on: December 17,2023

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on:December 17,2023

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r

Updated on: October 12,2023

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r

Updated on:October 12,2023

Researchers identify molecular characteristics of leptomeningeal melanoma metastases

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Patients w

Updated on: December 20,2023

Researchers identify molecular characteristics of leptomeningeal melanoma metastases

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Patients w

Updated on:December 20,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on: December 21,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on:December 21,2023